| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 8.428 | - | 28.353 | 55.810 | 59.736 | 55.363 | 69.912 |
| Total Income - EUR | - | - | - | 17.561 | - | 29.468 | 55.810 | 59.736 | 55.363 | 69.912 |
| Total Expenses - EUR | - | - | - | 17.285 | - | 27.025 | 31.249 | 32.920 | 49.302 | 67.011 |
| Gross Profit/Loss - EUR | - | - | - | 275 | - | 2.443 | 24.561 | 26.817 | 6.061 | 2.901 |
| Net Profit/Loss - EUR | - | - | - | 100 | - | 2.170 | 24.003 | 26.219 | 5.505 | 779 |
| Employees | - | - | - | 4 | - | 3 | 3 | 2 | 2 | 2 |
Check the financial reports for the company - Tripodent S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 18.437 | - | 16.682 | 12.828 | 9.488 | 100.630 | 110.725 |
| Current Assets | - | - | - | 2.298 | - | 1.823 | 1.465 | 2.545 | 17.056 | 15.051 |
| Inventories | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 104 | - | 0 | 575 | 81 | 15.918 | 11.341 |
| Cash | - | - | - | 2.193 | - | 1.823 | 889 | 2.464 | 1.139 | 3.710 |
| Shareholders Funds | - | - | - | -80.610 | - | -76.678 | -50.975 | -24.914 | -19.333 | -18.446 |
| Social Capital | - | - | - | 43 | - | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 101.345 | - | 95.183 | 65.267 | 36.947 | 137.019 | 144.222 |
| Income in Advance | - | - | - | 0 | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Tripodent S.r.l.